| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |